WALTHAM, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review designation of the supplemental New Drug Application (sNDA) for EMPAVELI^® (pegcetacoplan) for C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN), which are severe and rare kidney diseases. The Prescription Drug User Fee Act (PDUFA) target action date is July 28, 2025.

Esteve Pharmaceuticals, S.A. will commercialize Increlex in all markets outside the U.S.

IRVINE, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader of compute and connectivity for IoT solutions enabling Edge AI Intelligence, today announced the appointment of Todd Rychecky as general manager and head of its Out-of-Band (OOB) Management Business Line. With a proven track record in network resilience, SaaS solutions and OOB management, Rychecky will play a pivotal role in expanding Lantronix’s market presence and driving strategic growth in this critical sector.

TUPELO, Miss., April 01, 2025 (GLOBE NEWSWIRE) -- Renasant Corporation (NYSE: RNST) (“Renasant” or “the Company”) announced today that it has completed its merger with The First Bancshares, Inc., the parent company of The First Bank (“The First”), effective April 1, 2025.

FREDERICK, Md., April 01, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapies for autoimmune diseases, today announced that its management expects to participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8, 2025, at 2:15 p.m. ET.

Acquisition of Electrochem Completed and Integration Has Commenced                

VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Marimaca Copper Corp. (“Marimaca” or the “Company”) (TSX: MARI) (ASX: MC2) is pleased to announce that the Company has been admitted to the official list of the Australian Securities Exchange (“ASX”) as a Foreign Exempt Listing, on March 31^st 2025 (AEDT), and that the securities of the Company will commence quotation at 13:00 (1:00pm) Australia Eastern Daylight Time (AEDT) on April 2^nd 2025.

LOS ALTOS, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta, M.D., Chief Executive Officer will present at the 24^th Annual Needham Virtual Healthcare Conference on Monday, April 7, at 2:15 p.m. ET.

STOCKHOLM, SWEDEN – April 1, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) annouces that Viktor Drvota today takes over as CEO of the portfolio company Umecrine Cognition. Viktor Drvota remains the CEO of Karolinska Development.

The Management Board of Bigbank AS approved the final allocation of the private placement of notes qualifying as Additional Tier 1 (AT1) own funds of the bank. A total of 300 bonds, each with a nominal value of EUR 10,000, were allocated to 38 investors. The initial issue volume of 3 million euros was fully subscribed.

KALMAR CORPORATION, TRADE PRESS RELEASE, 1 APRIL 2025 AT 2:00 PM (EEST)

Company continues to progress toward the signing of a definitive merger agreement with Renovaro

THE WOODLANDS, Texas, April 01, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) announced that it has completed its previously-announced acquisition (the “Transaction”) of the Central Basin Platform (“CBP”) assets of Lime Rock Resources IV, LP (“Lime Rock”) on March 31, 2025. Lime Rock’s CBP operations are located in the Permian Basin in Andrews County, Texas, and are focused on the development of approximately 17,700 net acres where the majority are similar to Ring’s existing CBP assets in the Shafter Lake area, and the remaining acreage exposes the Company to new active plays.

HAMPTON, N.H., April 01, 2025 (GLOBE NEWSWIRE) -- Unitil Corporation (NYSE: UTL) (unitil.com) today announced that it has entered into a definitive agreement to acquire Maine Natural Gas Company (“Maine Natural”) from Avangrid Enterprises, Inc., for $86.0 million on a debt-free basis, subject to adjustment for closing working capital and transaction expenses. Upon closing of the transaction, which is expected to occur by the end of 2025, Maine Natural will become a wholly owned subsidiary of Unitil. The transaction is subject to approval by the Maine Public Utilities Commission.

The acquisition meets growing demand for personalized credit experiences online

FORM 8.5 (EPT/RI)

Achieved Full Year 2024 Revenue of $19.7 Million

FORM 8.3